5-MeO-NBpBrT: Difference between revisions

5-MeO-NBpBrT
Identifiers
	IUPAC name N-(4-Bromobenzyl)-2-(5-methoxy-1H-indol-3-yl)ethanamine;
PubChem CID	5124753;
ChemSpider	4299315 ;
ChEMBL	ChEMBL57427 ;
CompTox Dashboard (EPA)	DTXSID901029953 ;
Chemical and physical data
Formula	C18H19BrN2O
Molar mass	359.260 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c3cc(Br)ccc3CNCCc(cnc1cc2)c1cc2OC;
	InChI InChI=1S/C18H19BrN2O/c1-22-16-6-7-18-17(10-16)14(12-21-18)8-9-20-11-13-2-4-15(19)5-3-13/h2-7,10,12,20-21H,8-9,11H2,1H3 ; Key:XHLOUFPZLUULGI-UHFFFAOYSA-N ;
	(verify)

Browse history interactively

← Previous edit Next edit →

Content deleted Content added

VisualWikitext

Inline

Revision as of 06:23, 11 March 2012

5-MeO-NBpBrT (5-Methoxy-N-(4-bromobenzyl)tryptamine) is a drug which acts as an antagonist for the 5-HT_2A receptor,^[1] with a claimed 100x selectivity over the closely related 5-HT_2C receptor.^[2] While N-benzyl substitution of psychedelic phenethylamines often results in potent 5-HT_2A agonists, N-benzyl tryptamines show much lower efficacy and are either very weak partial agonists or antagonists at 5-HT_2A.^[3]^[4]

References

^ Niels Jensen. Tryptamines as Ligands and Modulators of the Serotonin 5-HT2A Receptor and the Isolation of Aeruginascin from the Hallucinogenic Mushroom Inocybe aeruginascens. PhD dissertation, Georg-August-Universität zu Göttingen, 2004.
^ Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K. Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines. Journal of Medicinal Chemistry. 1994 Jun 24;37(13):1929-35. PMID 8027974
^ Maria Silva PhD. Theoretical study of the interaction of agonists with the 5-HT2A receptor. Universität Regensburg, 2009.
^ Silva ME, Heim R, Strasser A, Elz S, Dove S (2011). "Theoretical studies on the interaction of partial agonists with the 5-HT(2A) receptor". Journal of Computer-aided Molecular Design. 25 (1): 51–66. doi:10.1007/s10822-010-9400-2. PMID 21088982. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[1] Niels Jensen. Tryptamines as Ligands and Modulators of the Serotonin 5-HT2A Receptor and the Isolation of Aeruginascin from the Hallucinogenic Mushroom Inocybe aeruginascens. PhD dissertation, Georg-August-Universität zu Göttingen, 2004.

[2] Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K. Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines. Journal of Medicinal Chemistry. 1994 Jun 24;37(13):1929-35. PMID 8027974

[3] Maria Silva PhD. Theoretical study of the interaction of agonists with the 5-HT2A receptor. Universität Regensburg, 2009.

[pmid21088982-4] Silva ME, Heim R, Strasser A, Elz S, Dove S (2011). "Theoretical studies on the interaction of partial agonists with the 5-HT(2A) receptor". Journal of Computer-aided Molecular Design. 25 (1): 51–66. doi:10.1007/s10822-010-9400-2. PMID 21088982. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

[1]

[2]

[3]

[4]

@@ Line 1: / Line 1: @@
+<!-- Please do not remove or change this AfD message until the issue is settled -->
-{{Drugbox
+{{Article for deletion/dated|page=2C-TFM|timestamp=20120311062324|year=2012|month=March|day=11|substed=yes}}
+<!-- For administrator use only: {{Old AfD multi|page=2C-TFM|date=11 March 2012|result='''keep'''}} -->
+<!-- End of AfD message, feel free to edit beyond this point --> {{Drugbox
 | verifiedrevid = 477345825
 | IUPAC_name = N-(4-Bromobenzyl)-2-(5-methoxy-1H-indol-3-yl)ethanamine

Revision as of 06:23, 11 March 2012

See also

References